The dose is deliberately high compared to classical peptides (5-10 mg for GLP-1 analogues, 2-5 mg for short regeneratives) because documented GHK-Cu protocols use larger quantities in trichological and cutaneous research (1-3 mg per injection, concentrated topical applications)
Theranostics , 8 , 45354551
Serious problems appear less common in study reports, but persistent vomiting, dehydration, symptoms of low blood sugar, allergic reactions, or severe abdominal pain deserve prompt medical review
This distinction matters for researchers because it means the BPC-157 peptides activity range was discovered through observation rather than design
Injection site redness (mild, transient) Minor swelling at injection area Occasional headache Mild nausea (typically resolves) Fatigue during initial days Sleep changes (some report disturbance, others improvement) Increased appetite Vivid dreams Temporary digestive changes Sleep effects vary considerably among users